Despite the above differences in treatment regimen, our unequivocally negative results with regard to DN amelioration indicate that the B7-1 pathway, be it podocyte or immune mediated, is unlikely to constitute a pivotal axis in the pathology of this model. Here, CD80 is linked to liver dysplastic nodule.